about
My approach to the treatment of sclerodermaPharmacotherapy of systemic sclerosisAnimal models of systemic sclerosis: their utility and limitations.Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.Scleroderma renal crisis or thrombotic thrombocytopenic purpura: seeing through the masquerade.Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibitionCorticosteroids and the risk of scleroderma renal crisis: a systematic review.Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.Scleroderma renal crisis: a pathology perspectiveCauses and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis.Informatics can identify systemic sclerosis (SSc) patients at risk for scleroderma renal crisis.Outcomes in systemic sclerosis-related lung disease after lung transplantation.Latest advances in connective tissue disorders.Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis.Complement activation and effect of eculizumab in scleroderma renal crisis.Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts.Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.Steroid-induced scleroderma renal crisis in an at-risk patient.Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia.Scleroderma renal crisis and renal involvement in systemic sclerosis.Lung Transplantation for Scleroderma-related Lung Disease.Extrahepatic Manifestations of Primary Biliary Cholangitis.Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.Scleroderma Renal Crisis in Mixed Connective Tissue Disease With Full Renal Recovery Within 3 Months: A Case Report With Expanding Treatment Modalities to Treat Each Clinical Sign as an Independent Entity.Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A.Troponin I and echocardiography in patients with systemic sclerosis and matched population controls.
P2860
Q24618843-83837797-0767-42FF-854B-5CB6B22BDA9EQ24629481-FDFCC8B2-9D6E-4F22-BA8F-47AF517A0BC8Q28390528-B3E7E49D-68D2-4300-A276-F56BCF02F13AQ33401182-A8E0D8DA-4EFA-420A-96FF-D863C31884EBQ33423227-42DB3EEC-2B8D-4ACD-8BF0-81F7482ECC9CQ33628275-B353287A-B34D-4531-BD4B-61E24B1FE646Q33763415-66BF25B8-018C-420E-9F43-D64ADBF8FA95Q34106037-E30D8856-3E80-4B1E-B749-46B7F24B9854Q34218928-4AFF1E0E-C583-4063-B93B-95F76C3F17D6Q36419007-8BF09075-FF98-4A84-BCB9-37D50DCCB508Q36590721-955CB603-207C-4776-B4CF-3CAAF622A570Q36739951-6617962A-C4F1-4958-B1D1-5861AA6CAD7DQ37058776-8DB70130-8A65-40A0-BF32-90FED9177AD0Q37423983-C7D222BF-57B7-426C-A783-A91BE0877615Q37605730-F4DEFA2C-3199-4848-81DF-3D69BFF1AA05Q37655603-9A118865-1845-49DE-8177-7577CAEA5172Q37956146-8EC4404E-2651-4577-8BD3-1D8BB8014A27Q38014264-D67B399A-9467-4EFE-9ABD-6F29011FBF1FQ38268067-CDE4EA49-12B2-47E1-B019-61236DA75AD8Q38414974-8F01C5EB-C1EC-44C6-8759-B3A939D1DB21Q38957950-FF4CE037-2A31-4EE1-B1CA-726F7D01C2B1Q39005017-9C5FC649-75E4-42C8-986B-ABC7C462FDB8Q39177903-C781951D-EC5C-4EC5-8086-67640928BD72Q41169103-DED777EF-2FC6-46FF-AA5F-C803AEF26D6CQ42375575-44E0857D-6646-4E87-958F-F6222EC891BEQ42492897-B71E0F02-A42F-439D-9B99-42B10F00DCD4Q48527574-F755CEF8-00BD-4B0C-B63C-AA0DA00D7473
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Renal complications and scleroderma renal crisis.
@ast
Renal complications and scleroderma renal crisis.
@en
type
label
Renal complications and scleroderma renal crisis.
@ast
Renal complications and scleroderma renal crisis.
@en
prefLabel
Renal complications and scleroderma renal crisis.
@ast
Renal complications and scleroderma renal crisis.
@en
P2093
P356
P1433
P1476
Renal complications and scleroderma renal crisis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEN483
P478
48 Suppl 3
P577
2009-06-01T00:00:00Z